Q2 2018 Holdings
Filed 2018-08-14 | 114 holdings | $292.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Homology Medicines Inc | COM | 438083107 | $106.6K | 5,227,035 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $109.5K | 6,609,894 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $130.4K | 6,988,248 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.7M | 250,000 | 2.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $12.9M | 3,491,922 | 4.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $14.4M | 146,000 | 4.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $16.7M | 729,948 | 5.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $21.0M | 2,305,773 | 7.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.5M | 350,000 | 10.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $30.3M | 741,016 | 10.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $32.1M | 482,467 | 11.0% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $34.7M | 6,063,496 | 11.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $37.0M | 447,029 | 12.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $54.8M | 2,745,705 | 18.7% |